Severe Neonatal Hyperbilirubinemia in Crigler-Najjar Syndrome Model Mice Can Be Reversed With Zinc Protoporphyrin

被引:10
|
作者
Fujiwara, Ryoichi [1 ,2 ,3 ]
Mitsugi, Ryo [3 ]
Uemura, Asuka [3 ]
Itoh, Tomoo [3 ]
Tukey, Robert H. [4 ]
机构
[1] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-70376 Stuttgart, Germany
[2] Univ Tubingen, Dept Biochem & Pharm, Tubingen, Germany
[3] Kitasato Univ, Dept Pharmaceut, Sch Pharm, Tokyo, Japan
[4] Univ Calif San Diego, Dept Pharmacol, Lab Environm Toxicol, La Jolla, CA 92093 USA
关键词
UDP-GLUCURONOSYLTRANSFERASE; 1A1; SERUM BILIRUBIN; HEME OXYGENASE; NONALCOHOLIC STEATOHEPATITIS; BILIVERDIN REDUCTASE; REDUCED EXPRESSION; UDP-GLUCURONOSYLTRANSFERASE-1;
D O I
10.1002/hep4.1082
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Neurotoxic bilirubin is solely conjugated by UDP-glucuronosyltransferase (UGT) 1A1. Due to an inadequate function of UGT1A1, human neonates develop mild to severe physiological hyperbilirubinemia. Accumulation of bilirubin in the brain leads to the onset of irreversible brain damage called kernicterus. Breastfeeding is one of the most significant factors that increase the risk of developing kernicterus in infants. Why does the most natural way of feeding increase the risk of brain damage or even death? This question leads to the hypothesis that breast milk-induced neonatal hyperbilirubinemia might bring certain benefits to the body. One of the barriers to answering the above question is the lack of animal models that display mild to severe neonatal hyperbilirubinemia. A mouse model that develops neonatal hyperbilirubinemia was previously developed by a knockout of the Ugt1 locus. Deletion of Ugt1a1 results in neonatal lethality from bilirubin neurotoxicity. Bilirubin is the end product of heme catabolism in which heme oxygenase-I is largely involved. When zinc protoporphyrin, an inhibitor of heme oxygenase I, was administered to newborn Ugt1(-/-) mice, serum bilirubin levels dropped dramatically, rescuing the mice from bilirubin-induced neonatal lethality. Zinc protoporphyrin-treated Ugt1(-/-) mice developed normally as adults capable of reproducing, but their newborns showed even more severe hyperbilirubinemia. Microarray analysis of the hyperbilirubinemic livers indicated that a number of genes associated with nucleotide, transport, and immune response were significantly down-regulated in a serum bilirubin level-dependent manner. Conclusion: Our study provides an opportunity to advance the development of effective therapeutics to effectively and rapidly prevent bilirubin-induced toxicity. Neonatal hyperbilirubinemia has various impacts on the body that could be driven by the antioxidant property of bilirubin.
引用
收藏
页码:792 / 802
页数:11
相关论文
共 50 条
  • [31] AAV 1 and 8 have higher efficacy than AAV 2 in correction of hyperbilirubinemia in the Gunn rat, the animal model for the metabolic liver dissorder Crigler-Najjar syndrome
    Bosma, PJ
    de Jong, B
    Looije, N
    Kunne, C
    Bakker, CT
    Seppen, J
    MOLECULAR THERAPY, 2004, 9 : S331 - S332
  • [32] Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer
    Bortolussi, Giulia
    Zentilin, Lorena
    Baj, Gabriele
    Giraudi, Pablo
    Bellarosa, Cristina
    Giacca, Mauro
    Tiribelli, Claudio
    Muro, Andres F.
    FASEB JOURNAL, 2012, 26 (03): : 1052 - 1063
  • [33] Phenotype heterogeneity of hyperbilirubinemia condition: The lesson by coinheritance of glucose-6-phosphate dehydrogenase deficiency and Crigler-Najjar Syndrome type II in an Italian patient
    Minucci, Angelo
    Canu, Giulia
    Tellone, Ester
    Giardina, Bruno
    Zuppi, Cecilia
    Capoluongo, Ettore
    BLOOD CELLS MOLECULES AND DISEASES, 2012, 49 (02) : 118 - 119
  • [34] Transplantation of isolated allogeneic hepatocytes in a patient with Crigler-Najjar syndrome type 1 resulted in excretion of bilirubin glucuronides in bile and partial amelioration of hyperbilirubinemia.
    Fox, IJ
    Chowdhury, JR
    Kaufman, SS
    Chowdhury, NR
    Kostrubsky, VE
    Sauter, B
    Strom, SC
    HEPATOLOGY, 1997, 26 (04) : 192 - 192
  • [35] CRISPR/Cas9-Mediated Gene Editing Corrects Disease-Causing Mutation in Crigler-Najjar Syndrome Mice
    Bortolussi, Giulia
    Schneider, Edoardo
    Porro, Fabiola
    Ferrucci, Filippo
    Iaconcig, Alessandra
    Bockor, Luka
    Galletta, Claudia
    Munoz, Cristian
    De Caneva, Alessia
    Braga, Luca
    Zentilin, Lorena
    Giacca, Mauro
    Muro, Andres F.
    MOLECULAR THERAPY, 2020, 28 (04) : 39 - 39
  • [36] Efficient Long Lasting AAV Gene Therapy in a Mouse Model of Crigler-Najjar Syndrome Type I: Coming of Age?
    Bockor, Luka
    Bortolussi, Giulia
    Zentilin, Lorena
    Chiaruttini, Giulia
    Giacca, Mauro
    Benvenuti, Federica
    Muro, Andres F.
    MOLECULAR THERAPY, 2014, 22 : S226 - S226
  • [37] EFFECT OF REPEATED PHLEBOTOMY ON BILIRUBIN TURNOVER, BILIRUBIN CLEARANCE AND UNCONJUGATED HYPERBILIRUBINEMIA IN CRIGLER-NAJJAR SYNDROME AND JAUNDICED GUNN RAT - APPLICATION OF COMPUTERS TO EXPERIMENTAL-DESIGN
    BERK, PD
    SCHARSCHMIDT, BF
    WAGGONER, JG
    WHITE, SC
    CLINICAL SCIENCE AND MOLECULAR MEDICINE, 1976, 50 (05): : 333 - 348
  • [38] Complete correction of hyperbilirubinemia in the Gunn rat model of Crigler-Najjar syndrome type I following transient in vivo adenovirus-mediated expression of human bilirubin UDP-glucuronosyltransferase
    Askari, FK
    Hitomi, Y
    Mao, M
    Wilson, JM
    GENE THERAPY, 1996, 3 (05) : 381 - 388
  • [39] Lipid nanoparticle-encapsulated mRNA therapy corrects serum total bilirubin level in Crigler-Najjar syndrome mouse model
    Greig, Jenny A.
    Chorazeczewski, Joanna K.
    Chowdhary, Vivek
    Smith, Melanie K.
    Jennis, Matthew
    Tarrant, James C.
    Buza, Elizabeth L.
    Coughlan, Kimberly
    Martini, Paolo G. V.
    Wilson, James M.
    MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2023, 29 : 32 - 39
  • [40] Correction of the UDP-glucuronosyltransferase gene defect in the Gunn rat model of Crigler-Najjar syndrome type I with a chimeric oligonucleotide
    Kren, BT
    Parashar, B
    Bandyopadhyay, P
    Chowdhury, NR
    Chowdhury, JR
    Steer, CJ
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10349 - 10354